Skip to Main Content

Author Details

Kara L Lynch
University of California San Francisco
2006
124
29
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35880962The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women: Quantification of Ketamine and Metabolites.J Psychoactive Drugs2023
37852006The Effect of Route of Administration and Vehicle on the Pharmacokinetics of THC and CBD in Adult, Neonate, and Breastfed Sprague-Dawley Rats.Cannabis Cannabinoid Res2023
37257181Predictive Value of <i>ABCC2</i> and <i>UGT1A1</i> Polymorphisms on Irinotecan-Related Toxicities in Patients with Cancer.Genet Test Mol Biomarkers2023
37450302Assessment of Adverse Reactions, Antibody Patterns, and 12-month Outcomes in the Mother-Infant Dyad After COVID-19 mRNA Vaccination in Pregnancy.JAMA Netw Open2023
37468623A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection.Nature2023
36857214Unexpected Fentanyl Detection during a Liver Transplant Evaluation.Clin Chem2023
36748419Detection of IgM, IgG, IgA and neutralizing antibody responses to SARS-CoV-2 infection and mRNA vaccination.J Med Microbiol2023
36875801Multiple substance use and blood pressure in women experiencing homelessness.Addict Behav Rep2023
36610415Development of a Machine Learning Algorithm for Drug Screening Analysis on High-Resolution UPLC-MSE/QTOF Mass Spectrometry.J Appl Lab Med2023
36909288A case series evaluation of comprehensive drug testing in the pediatric acute care setting.J Mass Spectrom Adv Clin Lab2023
34351422Development of an LC-MS/MS Method for Measurement of Irinotecan and Its Major Metabolites in Plasma: Technical Considerations.Lab Med2022
35661895Increased Serum IgG Antibody, Avidity, and Surrogate Virus Neutralization Response after a Third Dose for the BNT162b2 mRNA Vaccine to SARS-CoV-2.J Appl Lab Med2022
35489334Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation.Cell2022
35750035Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation.Cell2022
36447819Transient expression of antinuclear RNP-A antibodies in patients with acute COVID-19 infection.J Transl Autoimmun2022
35908075Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancy.Nat Commun2022
35872529Multiple substance use, inflammation and cardiac stretch in women living with HIV.Drug Alcohol Depend2022
36338506Hospitalized Patients With COVID-19 Have Higher Plasma Aldosterone-Renin Ratio and Lower ACE Activity Than Controls.J Endocr Soc2022
35866847Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection.AIDS2022
36065325Development and application of a High-Resolution mass spectrometry method for the detection of fentanyl analogs in urine and serum.J Mass Spectrom Adv Clin Lab2022
36036092An Opioid Hiding in Plain Sight: Loperamide-Induced False-Positive Fentanyl and Buprenorphine Immunoassay Results.J Appl Lab Med2022
36300623Autoantibody discovery across monogenic, acquired, and COVID-19-associated autoimmunity with scalable PhIP-seq.Elife2022
36168954Impact of multiple substance use on circulating ST2, a biomarker of adverse cardiac remodelling, in women.Biomarkers2022
33506876Establishment of a High-Resolution Liquid Chromatography-Mass Spectrometry Spectral Library for Screening Toxic Natural Products.J Anal Toxicol2022
35036987Development of a high-throughput differential mobility separation-tandem mass spectrometry (DMS-MS/MS) method for clinical urine drug testing.J Mass Spectrom Adv Clin Lab2022
35026018Adequate Antibody Response to COVID-19 Vaccine in Patients with Monoclonal Gammopathies and Light Chain Amyloidosis.Lab Med2022
34864962Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational Study.Clin Infect Dis2022
35018416Evaluation of Neutralizing Antibodies against SARS-CoV-2 Variants after Infection and Vaccination Using a Multiplexed Surrogate Virus Neutralization Test.Clin Chem2022
34648027Rate of Serum SARS-CoV-2 Antibody Decline for Two mRNA Vaccines.J Appl Lab Med2022
34673360Ongoing tobacco use in women who experience homelessness and unstable housing: A prospective study to inform tobacco cessation interventions and policies.Addict Behav2022
34787039Mistaken identity: acute respiratory arrest from accidental ingestion of poison hemlock.Clin Toxicol (Phila)2022
32927483Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Avidity Maturation and Association with Disease Severity.Clin Infect Dis2021
33827900A SARS-CoV-2 Label-Free Surrogate Virus Neutralization Test and a Longitudinal Study of Antibody Characteristics in COVID-19 Patients.J Clin Microbiol2021
33677311Cocaine Use and White Matter Hyperintensities in Homeless and Unstably Housed Women.J Stroke Cerebrovasc Dis2021
33758859Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19: Anti-IFN antibodies in critical COVID-19 correlate with poor ISG response and upregulation of LAIR1 surface protein in PBMCs.bioRxiv2021
33564754Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco.Res Sq2021
33501951Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.Clin Infect Dis2021
34931183Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and early infancy.Res Sq2021
34671772SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy.bioRxiv2021
34405093Characteristics of High-Titer Convalescent Plasma and Antibody Dynamics After Administration in Patients With Severe Coronavirus Disease 2019.Open Forum Infect Dis2021
34429372Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19.Sci Transl Med2021
34395717Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue Disease.Open Forum Infect Dis2021
34534316The Reference Range for the Anion Gap Is Dependent on the Instrument's Electrolyte Assay.J Appl Lab Med2021
33933189SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study.Lancet HIV2021
34117227Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco using electronic health records.Nat Commun2021
34358289Diagnostic Value of Nucleocapsid Protein in Blood for SARS-CoV-2 Infection.Clin Chem2021
34260965Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19.Cell Rep2021
33950934Lacosamide induced Brugada I morphology in the setting of septicemia: A case report.Medicine (Baltimore)2021
33399201Hospital-Based Donor Recruitment and Predonation Serologic Testing for COVID-19 Convalescent Plasma.Am J Clin Pathol2021
33382901Evaluation of Biomarkers in Sepsis: High Dimethylarginine (ADMA and SDMA) Concentrations Are Associated with Mortality.J Appl Lab Med2021
  • 1 - 50 of 124

Recommended Authors

Mayo Clinic College of Medicine
Career Start Year 2018
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2011
Number of shared co-authors 0
David Geffen School of Medicine, university of california los angeles
Career Start Year 2010
Number of shared co-authors 1
University of Utah Health Sciences Center
Career Start Year 2009
Number of shared co-authors 2
Department of Emergency and Hospital Medicine, 7USF Morsani College of Medicine
Career Start Year 2009
Number of shared co-authors 0
Nationwide Children's Hospital, College of Medicine, The Ohio State University
Career Start Year 2008
Number of shared co-authors 0
University of Toronto
Career Start Year 2007
Number of shared co-authors 1
Department of Pharmacy, Massachusetts General Hospital
Career Start Year 2007
Number of shared co-authors 0
University of Texas Health Science Center
Career Start Year 2006
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 2006
Number of shared co-authors 0
Seoul National University Bundang Hospital and College of Medicine
Career Start Year 2002
Number of shared co-authors 0
University of Virginia Health System
Career Start Year 2001
Number of shared co-authors 0
Ann Robert H. Lurie Childrens Hospital of Chicago
Career Start Year 2000
Number of shared co-authors 0
Clinical Evidence Generation, Eisai Inc.
Career Start Year 1999
Number of shared co-authors 0
and of Biochemistry and Pharmacy, University of Tuebingen
Career Start Year 1996
Number of shared co-authors 1
Department of Pharmacy, Boston Children's Hospital
Career Start Year 1996
Number of shared co-authors 0
Faculty of Pharmacy, Suez Canal University
Career Start Year 1995
Number of shared co-authors 0
Universite Paris Saclay
Career Start Year 1994
Number of shared co-authors 0
BC Children's Hospital Research Institute
Career Start Year 1991
Number of shared co-authors 0
University of Louisville
Career Start Year 1991
Number of shared co-authors 1
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1990
Number of shared co-authors 0
Center for Drug Evaluation and Research
Career Start Year 1989
Number of shared co-authors 0
university of california san diego Health, Center for Advanced Laboratory Medicine
Career Start Year 1988
Number of shared co-authors 2
Schulich School of Medicine and Dentistry, University of Western Ontario
Career Start Year 1986
Number of shared co-authors 0
ReNeuroGen LLC
Career Start Year 1985
Number of shared co-authors 0
Department of Pharmaceutics, University of Florida
Career Start Year 1979
Number of shared co-authors 0
Harvard T.H. Chan School of Public Health
Career Start Year 1975
Number of shared co-authors 0
Center for Pharmacoepidemiology and Treatment Science, Rutgers University
Career Start Year 1970
Number of shared co-authors 1
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1968
Number of shared co-authors 0

Collaborators

University of California san francisco
Co-authored papers 55
University of California san francisco
Co-authored papers 7
University of California San Francisco School of Medicine
Co-authored papers 6
Gladstone Institute of Virology, USA University of California san francisco
Co-authored papers 4
Diabetes Center, University of California san francisco
Co-authored papers 4
University of California San Francisco School of Medicine
Co-authored papers 4
University of California san francisco
Co-authored papers 4
Gladstone-UCSF Institute of Genomic Immunology
Co-authored papers 4
University of California san francisco
Co-authored papers 3
Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 3
The Salk Institute for Biological Studies
Co-authored papers 3
Scientific Services
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
University of California San Francisco
Co-authored papers 3
Weill Institute for Neurosciences, University of California-San Francisco
Co-authored papers 3
Vitalant Research Institute
Co-authored papers 3
University of California san francisco
Co-authored papers 3
University of California San Francisco
Co-authored papers 3
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Massachusetts General Hospital
Co-authored papers 2
University of California san francisco
Co-authored papers 2
San Francisco General Hospital, University of California
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Gladstone-UCSF Institute of Genomic Immunology
Co-authored papers 2
University of California san francisco
Co-authored papers 2
University of California san francisco
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 2